Literature DB >> 20357250

TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.

Elize A Hayashi1, Alessandra Granato, Luciana S Paiva, Alvaro L Bertho, Maria Bellio, Alberto Nobrega.   

Abstract

We have previously shown that TLR4 triggering promotes the generation of CD23(+)CD93(+) transitional T2-like cells in vitro from mouse B cell precursors, suggesting a possible role for this receptor in B cell maturation. In this study, we perform an extensive study of cell surface markers and functional properties of B cells matured in vitro with LPS, comparatively with the well-known B cell maturation factor B lymphocyte-activating factor (BAFF). LPS increased generation of CD23(+) transitional B cells in a TLR4-dependent way, upregulating IgD and CD21 and downregulating CD93, without inducing cell proliferation, in a manner essentially equivalent to BAFF. For both BAFF and LPS, functional maturation of the IgM(+)CD23(+)CD93(+) cells was confirmed by their higher proliferative response to anti-CD40 plus IL-4 compared with IgM(+)CD23(neg)CD93(+) cells. BAFF-R-Fc-mediated neutralization experiments showed that TLR4-induced B cell maturation was independent of BAFF. Distinct from BAFF, maturation by LPS relied on the activation of canonical NF-kappaB pathway, and the two factors together had complementary effects, leading to higher numbers of IgM(+)CD23(+)CD93(+) cells with their simultaneous addition. Importantly, BCR cross-linking abrogated the generation of CD23(+) B cells by LPS or BAFF, indicating that signals mimicking central tolerance act on both systems. Addition of cyclosporin A reverted BCR-mediated inhibition, both for BAFF and LPS, suggesting similar regulation of signaling pathways by calcineurin. Finally, LPS-injected mice showed a rapid increase of mature B cells in the bone marrow, suggesting that TLR4 signaling may effectively stimulate B cell maturation in vivo, acting as an accessory stimulus in B cell development, complementary to the BAFF physiological pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357250     DOI: 10.4049/jimmunol.0903253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance.

Authors:  Melanie P Matheu; Yan Su; Milton L Greenberg; Caroline A Blanc; Ian Parker; David W Scott; Michael D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-17       Impact factor: 11.205

2.  The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.

Authors:  Ayesh K Seneviratne; Mingjing Xu; Juan J Aristizabal Henao; Val A Fajardo; Zhenyue Hao; Veronique Voisin; G Wei Xu; Rose Hurren; S Kim; Neil MacLean; Xiaoming Wang; Marcela Gronda; Danny Jeyaraju; Yulia Jitkova; Troy Ketela; Michael Mullokandov; David Sharon; Geethu Thomas; Raphaël Chouinard-Watkins; James R Hawley; Caitlin Schafer; Helen Loo Yau; Zaza Khuchua; Ahmed Aman; Rima Al-Awar; Atan Gross; Steven M Claypool; Richard P Bazinet; Mathieu Lupien; Steven Chan; Daniel D De Carvalho; Mark D Minden; Gary D Bader; Ken D Stark; Paul LeBlanc; Aaron D Schimmer
Journal:  Cell Stem Cell       Date:  2019-03-28       Impact factor: 24.633

3.  Effects of TNF inhibitor on innate inflammatory and Th17 cytokines in stimulated whole blood from rheumatoid arthritis patients.

Authors:  Sladjana Zivojinovic; Nada Pejnovic; Mirjana Sefik-Bukilica; Ljiljana Kovacevic; Ivan Soldatovic; Diana Bugarski; Slavko Mojsilovic; Nemanja Damjanov
Journal:  Inflammopharmacology       Date:  2012-06-24       Impact factor: 4.473

4.  Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.

Authors:  Tereza Martinu; Christine V Kinnier; Kymberly M Gowdy; Francine L Kelly; Laurie D Snyder; Dianhua Jiang; W Michael Foster; Stavros Garantziotis; John A Belperio; Paul W Noble; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2011-03-27       Impact factor: 10.247

5.  VISA is required for B cell expression of TLR7.

Authors:  Liang-Guo Xu; Lei Jin; Bi-Cheng Zhang; Linda J Akerlund; Hong-Bing Shu; John C Cambier
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

6.  Toll-like receptor 4-mediated signaling regulates IL-7-driven proliferation and differentiation of B-cell precursors.

Authors:  Qian Li; Dongmei Han; Wei Wang; Xiaoqing Liu; Xiuyuan Sun; Jun Zhang; Rong Li; Yu Zhang
Journal:  Cell Mol Immunol       Date:  2013-12-09       Impact factor: 11.530

7.  Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.

Authors:  JunMei Zhang; Ge Jia; Qun Liu; Jue Hu; Mei Yan; BaiFeng Yang; Huan Yang; WenBin Zhou; Jing Li
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

8.  Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast.

Authors:  Naureen Ehsan; Sheeba Murad; Tamour Ashiq; Muhammad Uzair Mansoor; Summer Gul; Samra Khalid; Muhammad Younas
Journal:  Tumour Biol       Date:  2013-01-22

Review 9.  Differential impact of Toll-like receptor signaling on distinct B cell subpopulations.

Authors:  Almut Meyer-Bahlburg; David J Rawlings
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 10.  Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Authors:  Elke S Bergmann-Leitner; Wolfgang W Leitner
Journal:  Vaccines (Basel)       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.